Cargando…

Isobavachalcone sensitizes cells to E2‐induced paclitaxel resistance by down‐regulating CD44 expression in ER+ breast cancer cells

Oestrogen receptor (ER) is expressed in approximately 60%‐70% of human breast cancer. Clinical trials and retrospective analyses have shown that ER‐positive (ER+) tumours are more tolerant to chemotherapeutic drug resistance than ER‐negative (ER−) tumours. In addition, isobavachalcone (IBC) is known...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Junfeng, Chen, Yi, Chen, Wenxing, Tang, Cuiju, Zhang, Honghong, Chen, Yuetong, Yang, Xiuwei, Xu, Zhi, Wei, Jingsun, Chen, Jinfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201375/ https://www.ncbi.nlm.nih.gov/pubmed/30179299 http://dx.doi.org/10.1111/jcmm.13719

Ejemplares similares

Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case report
por: Dai, Jiali, et al.
Publicado: (2020)

Establishment and Characterization of gc-006-03, a Novel Human Signet Ring Cell Gastric Cancer Cell Line Derived from Metastatic Ascites
por: Su, Xinyu, et al.
Publicado: (2018)

Influence of TS (rs34743033) and RUNX1 (rs2014300) gene polymorphisms on survival outcomes of fluorouracil-based chemotherapy in Chinese advanced gastric cancer patients
por: Han, Rongbo, et al.
Publicado: (2018)

Identification of biomarkers and their functions in dasatinib-resistant pancreatic cancer using bioinformatics analysis
por: Wei, Jingsun, et al.
Publicado: (2019)

Establishment and characterization of the GC-030-35 cell line derived from gastric hepatoid adenocarcinoma
por: Wei, Jingsun, et al.
Publicado: (2019)

Isobavachalcone inhibits the proliferation and invasion of tongue squamous cell carcinoma cells
por: Shi, Yi, et al.
Publicado: (2017)

Heterologous biosynthesis of isobavachalcone in tobacco based on in planta screening of prenyltransferases
por: Guo, Lirong, et al.
Publicado: (2022)

Isobavachalcone inhibits Pseudorabies virus by impairing virus-induced cell-to-cell fusion
por: Wang, Yu, et al.
Publicado: (2020)

Antibacterial Activity of Isobavachalcone (IBC) Is Associated with Membrane Disruption
por: de Assis, Leticia Ribeiro, et al.
Publicado: (2022)

Isobavachalcone Induces Multiple Cell Death in Human Triple-Negative Breast Cancer MDA-MB-231 Cells
por: Wu, Cheng-Zhu, et al.
Publicado: (2022)

Isobavachalcone induces the apoptosis of gastric cancer cells via inhibition of the Akt and Erk pathways
por: JIN, XIAOHONG, et al.
Publicado: (2016)

The efficacy and safety of irinotecan ± bevacizumab compared with oxaliplatin ± bevacizumab for metastatic colorectal cancer: A meta-analysis
por: Dai, Jiali, et al.
Publicado: (2019)

Isobavachalcone from Angelica keiskei Inhibits Adipogenesis and Prevents Lipid Accumulation
por: Lee, Hyejin, et al.
Publicado: (2018)

Isobavachalcone Induces ROS-Mediated Apoptosis via Targeting Thioredoxin Reductase 1 in Human Prostate Cancer PC-3 Cells
por: Li, Kai, et al.
Publicado: (2018)

Isobavachalcone as an Active Membrane Perturbing Agent and Inhibitor of ABCB1 Multidrug Transporter
por: Palko-Łabuz, Anna, et al.
Publicado: (2021)

Targeting Ovarian Cancer Cells Overexpressing CD44 with Immunoliposomes Encapsulating Glycosylated Paclitaxel
por: Khayrani, Apriliana Cahya, et al.
Publicado: (2019)

Cocktail of isobavachalcone and curcumin enhance eradication of Staphylococcus aureus biofilm from orthopedic implants by gentamicin and alleviate inflammatory osteolysis
por: Chen, Yan, et al.
Publicado: (2022)

Chemokine CCL20 promotes the paclitaxel resistance of CD44(+)CD117(+) cells via the Notch1 signaling pathway in ovarian cancer
por: Chen, Min, et al.
Publicado: (2021)

Increased invasion and tumorigenicity capacity of CD44(+)/CD24(-) breast cancer MCF7 cells in vitro and in nude mice
por: Yan, Wenxing, et al.
Publicado: (2013)

Isobavachalcone Activates Antitumor Immunity on Orthotopic Pancreatic Cancer Model: A Screening and Validation
por: Liu, Xuanming, et al.
Publicado: (2022)

Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation in Vivo
por: Ma, Peilin, et al.
Publicado: (2023)

Isobavachalcone From Cullen corylifolium Presents Significant Antibacterial Activity Against Clostridium difficile Through Disruption of the Cell Membrane
por: Liu, Xi-Wang, et al.
Publicado: (2022)

Isobavachalcone inhibits post-entry stages of the porcine reproductive and respiratory syndrome virus life cycle
por: Wang, Hai-Ming, et al.
Publicado: (2018)

Field Control Effect and Initial Mechanism: A Study of Isobavachalcone against Blister Blight Disease
por: Yang, Xiuju, et al.
Publicado: (2023)

Alloreactive cytotoxic T lymphocyte immunotherapy treatment of a patient with metastatic prostate cancer: A case report
por: Shi, Junfeng, et al.
Publicado: (2018)

CD44 Staining of Cancer Stem-Like Cells Is Influenced by Down-Regulation of CD44 Variant Isoforms and Up-Regulation of the Standard CD44 Isoform in the Population of Cells That Have Undergone Epithelial-to-Mesenchymal Transition
por: Biddle, Adrian, et al.
Publicado: (2013)

CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
por: Zhang, Jun, et al.
Publicado: (2021)

Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt/β-catenin signaling pathway
por: Chen, Yi, et al.
Publicado: (2022)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Publicado: (1996)

Hyaluronan–CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9
por: Spessotto, Paola, et al.
Publicado: (2002)

Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway
por: Jing, Haoran, et al.
Publicado: (2017)

Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
por: Montero-Montero, Lucía, et al.
Publicado: (2020)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

CD44 promotes cell proliferation in non-small cell lung cancer
por: Hu, Bo, et al.
Publicado: (2018)

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
por: Li, Zhonghu, et al.
Publicado: (2014)

Cell-in-cell structure mediates in-cell killing suppressed by CD44
por: Su, Yan, et al.
Publicado: (2022)

Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11
por: Chen, Yi, et al.
Publicado: (2021)

Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma
por: Xia, Tian, et al.
Publicado: (2021)

Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer
por: Zhou, Jin-Yong, et al.
Publicado: (2016)

Isobavachalcone isolated from Psoralea corylifolia inhibits cell proliferation and induces apoptosis via inhibiting the AKT/GSK-3β/β-catenin pathway in colorectal cancer cells
por: Li, Yanxi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bvhuv30353a4rg5fn3ci3v3pdo